We are live on ! Find out more
SFI

Susquehanna Fundamental Investments Portfolio holdings

AUM $2.67B
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+21.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.93B
AUM Growth
+$375M
Cap. Flow
+$284M
Cap. Flow %
9.67%
Top 10 Hldgs %
17.73%
Holding
717
New
167
Increased
119
Reduced
142
Closed
168

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$55.5M
2
CTAS icon
Cintas
CTAS
+$50.7M
3
MRSH
Marsh
MRSH
+$50M
4
PAYX icon
Paychex
PAYX
+$49.4M
5
CME icon
CME Group
CME
+$49.3M

Top Sells

Rank Stock Value
1
NEM icon
Newmont
NEM
+$65.7M
2
HON icon
Honeywell
HON
+$51.1M
3
SNOW icon
Snowflake
SNOW
+$39.5M
4
MCK icon
McKesson
MCK
+$36.5M
5
CVS icon
CVS Health
CVS
+$33.5M

Sector Composition

Rank Sector Weight
1 Financials 27.25%
2 Technology 24.46%
3 Industrials 21.41%
4 Materials 4.68%
5 Consumer Staples 4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCO icon
551
Acco Brands
ACCO
$399M
-15,422
Closed -$61.5K
ACHR icon
552
Archer Aviation
ACHR
$4.84B
-120,750
Closed -$1.16M
ACI icon
553
Albertsons Companies
ACI
$5.83B
-459,093
Closed -$8.04M
ACIW icon
554
ACI Worldwide
ACIW
$5.33B
-12,310
Closed -$650K
ADTN icon
555
Adtran
ADTN
$665M
-68,120
Closed -$639K
AGL icon
556
Agilon Health
AGL
$1.45B
-993
Closed -$25.6K
AIN icon
557
Albany International
AIN
$1.81B
-24,049
Closed -$1.28M
AJG icon
558
Arthur J. Gallagher & Co
AJG
$65.5B
-23,311
Closed -$7.22M
AKRO
559
DELISTED
Akero Therapeutics
AKRO
-14,080
Closed -$669K
ALNT icon
560
Allient
ALNT
$1.94B
-14,516
Closed -$650K
ALSN icon
561
Allison Transmission
ALSN
$10.2B
-11,351
Closed -$963K
AMC icon
562
AMC Entertainment Holdings
AMC
$2.26B
-447,697
Closed -$1.3M
AMN icon
563
AMN Healthcare
AMN
$1.26B
-64,179
Closed -$1.24M
AMP icon
564
Ameriprise Financial
AMP
$49.9B
-5,333
Closed -$2.62M
AMPH icon
565
Amphastar Pharmaceuticals
AMPH
$850M
-12,568
Closed -$335K
AN icon
566
AutoNation
AN
$6.9B
-4,284
Closed -$937K
ATRC icon
567
AtriCure
ATRC
$2.22B
-75,922
Closed -$2.68M
AVA icon
568
Avista
AVA
$3.23B
-37,878
Closed -$1.43M
AWI icon
569
Armstrong World Industries
AWI
$7.75B
-13,937
Closed -$2.73M
BBIO icon
570
BridgeBio Pharma
BBIO
$16.4B
-86,394
Closed -$4.49M
BHVN icon
571
Biohaven
BHVN
$2.17B
-61,988
Closed -$930K
BJ icon
572
BJs Wholesale Club
BJ
$11.8B
-41,865
Closed -$3.9M
BKR icon
573
Baker Hughes
BKR
$63.8B
-12,528
Closed -$610K
BLND icon
574
Blend Labs
BLND
$331M
-32,608
Closed -$119K
BOOM icon
575
DMC Global
BOOM
$155M
-42,610
Closed -$360K

Similar funds

Susquehanna Fundamental Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Susquehanna Fundamental Investments held 717 positions worth $2.93B, up 15% from $2.56B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Susquehanna Fundamental Investments deployed $284M of net new capital in Q4 2025, opening 167 new positions and adding to 119 existing holdings. Its largest new stake was Cintas: 268,914 shares worth $50.6M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Newmont, an estimated $65.7M trimmed.

  • Susquehanna Fundamental Investments's largest Q4 2025 buy was Cintas: 268,914 shares worth $50.6M.
  • Susquehanna Fundamental Investments added most to Automatic Data Processing in Q4 2025, an estimated $55.5M increase.
  • Susquehanna Fundamental Investments's biggest Q4 2025 reduction was Newmont, cutting an estimated $65.7M.
  • Susquehanna Fundamental Investments fully exited Honeywell in Q4 2025, selling an estimated $51.1M.
  • Susquehanna Fundamental Investments's ten largest holdings make up 18% of its $2.93B portfolio in Q4 2025.
  • Susquehanna Fundamental Investments opened 167 new positions and closed 168 in Q4 2025.
  • Susquehanna Fundamental Investments's portfolio value rose 15% quarter-over-quarter to $2.93B.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.